Christine Pascual’s phone started buzzing while she was at work in a hair salon with messages saying former Philippine ...

The Physicians Committee for Responsible Medicine, a nonprofit that advocates for nonanimal science, is applauding the new ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...

Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

In late March, Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced 10,000 layoffs across ...

Biotech leaders urge Senate intervention as FDA restructuring risks expertise loss impacting operations. Read more here.

Azcona, president of Mercury Group of Companies, has recently passed away, according to Unilab Inc. She was 69 years old. The ...

The FDA has set a goal date of Aug. 27, 2025. If approved, the therapy would be branded as Lytenava and be the first ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...

MANILA — Families of Philippine drug war victims who say they have been targeted by a "coordinated" campaign of online ...